Market Tracker

09/22 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

3.17
Delayed Data
As of 4:00pm ET
 -0.10 / -3.06%
Today’s Change
1.93
Today|||52-Week Range
3.77
+49.53%
Year-to-Date

Today’s Trading

Previous close3.27
Today’s open3.28
Day’s range3.11 - 3.28
Volume1,818,165
Average volume (3 months)1,753,550
Market cap$503.8M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)+56.41%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio7.2
Price/Sales1.45
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.10+0.64%
NKNantKwest Inc+0.09+1.66%
SYRSSyros Pharmaceutical...-0.53-3.43%
CYADCelyad SA+3.17+5.86%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director &
CAO
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts